SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

H.C. Wainwright Reiterates Buy on Navidea Biopharmaceutical, Raises Price Target to $4

H.C. Wainwright analyst Vernon Bernardino reiterates Navidea Biopharmaceutical (AMEX:NAVB) with a Buy and raises the price target from $3 to $4.

Benzinga · 03/02/2020 12:22

H.C. Wainwright analyst Vernon Bernardino reiterates Navidea Biopharmaceutical (AMEX:NAVB) with a Buy and raises the price target from $3 to $4.